Records containing: Melanoma (Skin Cancer)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-29SESAME: Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
-
CLINICAL_TRIALS study record update · 2026-10-27A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Continuous Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced/Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-10-26ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort
-
CLINICAL_TRIALS study record update · 2026-10-26Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis
-
CLINICAL_TRIALS study record update · 2026-10-22A Phase 1b/2 Trial Investigating the Safety and Efficacy of Oral AMXT 1501 and Oral DFMO in Combination With Standard of Care in Patients With Advanced Solid Tumors Who Progressed After Prior Therapies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-10-16Digital Phenotyping of Psychological Distress in Skin Cancer Patients: A Transformer-Based Analysis of Chinese Social Media Content
-
CLINICAL_TRIALS study record update · 2026-10-15A Prospective, Single-Center, Open-Label Exploratory Study of 68Ga-SorB PET/CT Imaging for the Diagnosis of Sortilin-Positive Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-10-09Evaluation of Skin Alterations and Epidermal Barrier Integrity in Patients Undergoing Pharmacological Cancer Treatments (EOSIN) and Wellbeing Oncological Survey (WOS): an Integrated Approach to Assessing Dermatological Effects and Quality of Life in Oncology Patients
-
CLINICAL_TRIALS study record update · 2026-10-06Biomechanical Characterization of Skin Properties Using Impact Based-Analysis Method (IBAM): Malignant Cutaneous Tumors vs. Healthy Cutaneous Tissues
-
CLINICAL_TRIALS study record update · 2026-09-24Molecular Residual Disease in Solid Tumors: A Prospective Study to Collect Clinical Data and Biospecimens to Support Discovery and Development of Cancer Biomarkers
-
CLINICAL_TRIALS study record update · 2026-09-15A Phase 1/2, Multicentre, Open-Label, Dose Escalation and Expansion Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of SL-28 in Patients With Advanced Solid Tumours
-
CLINICAL_TRIALS study record update · 2026-04-27Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma, a Randomized Phase III Multi-center Non- Inferiority Trial: MagMen-II
-
CLINICAL_TRIALS study record update · 2026-04-22A Multicenter, Open-Label, Randomized, Controlled Study to Assess the Antitumor Activity of LNS8801 With and Without Pembrolizumab in Patients With Treatment-Refractory, Unresectable Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase 2, Multicenter, Open-label Study of Lifileucel (Tumor-infiltrating Lymphocytes [TIL]) in Participants With Previously Treated Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-16Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
-
CLINICAL_TRIALS study record update · 2026-04-15The Value of Circulating Tumour DNA in Risk Stratification in Melanoma
-
CLINICAL_TRIALS study record update · 2026-04-15Multicenter Phase 3 Randomized Controlled Trial of NO Re-excision MelanomA - NORMA 2
-
CLINICAL_TRIALS study record update · 2026-03-30A Single-Arm, Single-Center, Phase II Exploratory Study of Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage IIB/III Acral Melanoma（TRIUMPH-AM）
-
CLINICAL_TRIALS study record update · 2026-03-13A Platform for Assessing Personal Risk of Developing or Recurring of Cancer: Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring of Subclinical Recurrences With Therapeutic Impact
-
CLINICAL_TRIALS study record update · 2026-03-12A Phase 1b/2 Trial Investigating the Safety and Efficacy of Oral AMXT 1501 and Oral DFMO in Combination With Standard of Care in Patients With Advanced Solid Tumors Who Progressed After Prior Therapies
-
CLINICAL_TRIALS study record update · 2026-03-09A Phase 2 Clinical Trial on Neoadjuvant Pembrolizumab in Patients Diagnosed With High-risk Melanoma Without Clinical Evidence of Metastatic Dissemination.
-
CLINICAL_TRIALS study record update · 2026-03-05PD-L1 Targeting Peptide Probe 68Ga-cPP-BCH for PET Imaging of Solid Tumor
-
CLINICAL_TRIALS study record update · 2026-03-03Digital Remote Patient Monitoring and Triage During Cancer Immunotherapy
-
CLINICAL_TRIALS study record update · 2026-02-25Adaptation and Implementation of an Evidence-Based Patient Navigation Intervention for Adolescent and Young Adult Cancer Survivors
-
CLINICAL_TRIALS study record update · 2026-02-24A Multi-Reader Multi-Case Study for Evaluating the Impact of Legit.Health Plus Device on the Healthcare Practitioners' Assessment of Skin Lesions